Renee Tannenbaum
Director/Board Member at CARDIFF ONCOLOGY, INC.
Net worth: 1 M $ as of 2024-04-29
Renee Tannenbaum active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CARDIFF ONCOLOGY, INC. | Director/Board Member | 2021-06-09 | - |
| Independent Dir/Board Member | 2021-06-09 | - | |
| ANI PHARMACEUTICALS, INC. | Director/Board Member | 2022-03-21 | - |
| Independent Dir/Board Member | 2022-03-21 | - |
Career history of Renee Tannenbaum
Former positions of Renee Tannenbaum
| Companies | Position | Start | End |
|---|---|---|---|
| ZOGENIX, INC. | Director/Board Member | 2015-02-05 | 2022-03-06 |
| Independent Dir/Board Member | 2015-02-05 | 2022-03-06 | |
Halozyme, Inc.
 Halozyme, Inc. BiotechnologyHealth Technology Part of Halozyme Therapeutics, Inc., Halozyme, Inc. is a company based in San Diego, CA. | Corporate Officer/Principal | 2016-07-31 | 2021-06-30 |
| THOR MEDICAL | Director/Board Member | 2016-05-18 | 2016-10-11 |
| CIPHER PHARMACEUTICALS INC. | Director/Board Member | 2016-03-31 | 2016-08-08 |
| ABBVIE INC. | Corporate Officer/Principal | 2012-09-30 | 2015-12-31 |
| SHARPS COMPLIANCE CORP. | Director/Board Member | 2012-02-29 | 2014-10-31 |
| Independent Dir/Board Member | 2012-10-02 | 2014-10-31 | |
Immune Pharmaceuticals Ltd.
 Immune Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Immune Pharmaceuticals, Inc., Immune Pharmaceuticals Ltd. develops pharmaceutical products for the treatment of cancer and pain. The company is based in Herzliya-Pituach, Israel. Immune Pharmaceuticals was acquired by EpiCept Corp. on August 26, 2013 for $21.43 million. | Director/Board Member | 2011-07-31 | 2012-11-08 |
| ░░░░░░ ░░░░░░ ░ ░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ ░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░ ░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Renee Tannenbaum
| University of Connecticut | Doctorate Degree |
| Temple University (Pennsylvania) | Masters Business Admin |
| Philadelphia College of Pharmacy | Doctorate Degree |
Statistics
International
| United States | 14 |
| Israel | 2 |
| Canada | 2 |
Operational
| Director/Board Member | 8 |
| Independent Dir/Board Member | 4 |
| Corporate Officer/Principal | 4 |
Sectoral
| Health Technology | 11 |
| Consumer Services | 5 |
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| ABBVIE INC. | Health Technology |
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| CARDIFF ONCOLOGY, INC. | Health Technology |
| ANI PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Sharps Compliance Corp.
 Sharps Compliance Corp. Miscellaneous Commercial ServicesCommercial Services Sharps Compliance Corp. engages in the provision of healthcare waste management services including medical, pharmaceutical, and hazardous. It focuses on developing management solutions for medical waste and unused dispensed medications generated by small and medium quantity generators. The company was founded in November 1992 and is headquartered in Houston, TX. | Commercial Services |
| The Bay Area Bioscience Association | Health Technology |
Immune Pharmaceuticals Ltd.
Immune Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Immune Pharmaceuticals, Inc., Immune Pharmaceuticals Ltd. develops pharmaceutical products for the treatment of cancer and pain. The company is based in Herzliya-Pituach, Israel. Immune Pharmaceuticals was acquired by EpiCept Corp. on August 26, 2013 for $21.43 million. | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Myrtle Potter & Co. LLC
 Myrtle Potter & Co. LLC Miscellaneous Commercial ServicesCommercial Services Myrtle Potter & Co. LLC provides life science and healthcare consulting services. The private company is based in San Jose, CA. The company was founded by Myrtle S. Potter. | Commercial Services |
Halozyme, Inc.
Halozyme, Inc. BiotechnologyHealth Technology Part of Halozyme Therapeutics, Inc., Halozyme, Inc. is a company based in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Renee Tannenbaum
- Experience
